Lysophosphatidylcholine as a Novel Diagnostic Biomarker in Kawasaki Disease: Based on Immunometabolism-Related Signature

Xiaomei Ma, Yang Zheng, Chenhui Feng, Mingming Zhang, Hongmao Wang, Xiaohui Li · 2025

Read Lysophosphatidylcholine as a Novel Diagnostic Biomarker in Kawasaki Disease: Based on Immunometabolism-Related Signature by Xiaomei Ma, Yang Zheng, Chenhui Feng, Mingming Zhang, Hongmao Wang, Xiaohui Li (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12766127.txt.

Description

Xiaomei Ma and co-authors nominate a fat molecule in blood as an early marker for Kawasaki disease, in work from twenty twenty-five. The disease inflames blood vessels in children for unknown reasons. Late diagnosis raises the risk of heart artery damage.

Broad metabolic scans first flagged a disturbed fat pathway in patients. Focused lipid tests then found twelve altered fat species. One, a lysophosphatidylcholine, held up on a protein style blood test with fair accuracy and strong specificity. Single cell gene data showed monocytes piling up in patients, with fat handling and inflammation genes both shifted. The authors tie the lipid shift to those immune cells and offer the marker for early detection work.

Catalog record

CREATORXiaomei Ma, Yang Zheng, Chenhui Feng, Mingming Zhang, Hongmao Wang, Xiaohui Li
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE37 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12766127

Browse the full library · About the Tower of Babel